Calcein-am|CAS 148504-34-1|DC Chemicals

Cas No.:	148504-34-1
Chemical Name:	Calcein-AM
Synonyms:	Glycine,N,N'-[[3',6'-bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl]bis(methylene)]bis[N-[2-[(acetyloxy)methoxy]-2-oxoethyl]-,1,1'-bis[(acetyloxy)methyl] ester;Calcein acetoxymethyl ester;Calcein, AM;Calcein-AM;Cellstain- Calcein-AM;Glycine,N,N s[(acetyloxy)methyl] ester;Glycine,N,N'-[[3',6'-bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl...;Glycine,N,N'-[[3',6'-bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl]bis(methylene)]bis[N-[2-[(acet;3',6'-DI(O-ACETYL)-2',7'-BIS(N,N-BIS(CARBOXYMETHYL)-AMINOMETHYL)FLUORESCEIN-TETRAACETOXYMETHYL ESTER;acetoxymethyl 2-[[2-(acetoxymethoxy)-2-oxo-ethyl]-[[3',6'-diacetoxy-7'-[[bis[2-(acetoxymethoxy)-2-oxo-ethyl]amino]methyl]-3-oxo-spiro;CAL-AM;CALCEIN AM, 4MM IN ANHYDROUS DMSO;calcein o,o'-diacetate tetrakis(acetoxymethyl)ester;CALCEIN-ACETOXYMETHYL ESTER, DIACETATE;CALCEIN-AM SOLUTION, 1 MMOL IN DMSO;-Cellstain-Calcein-AmSolution;Calcein O,O′-diacetate tetrakis(acetoxymethyl) ester;NSC 689290;Calcein AM solution;Calcein, AM CAS 148504-34-1*;Calcein AM solution;BCP23841;YFA50434;B7755;Calcein AM solution, 4 mM in DMSO, >=90% (HPLC), solution;N,N'-[[3',6'-Bis(acetyloxy)-oxospiro[isobenzofuran-1-(3H),9'-(9H)xanthene]-4',5'-diyl]bis(methy
SMILES:	O1C(C2=C([H])C([H])=C([H])C([H])=C2C21C1C([H])=C([H])C(=C(C([H])([H])N(C([H])([H])C(=O)OC([H])([H])OC(C([H])([H])[H])=O)C([H])([H])C(=O)OC([H])([H])OC(C([H])([H])[H])=O)C=1OC1C(=C(C([H])=C([H])C2=1)OC(C([H])([H])[H])=O)C([H])([H])N(C([H])([H])C(=O)OC([H])([H])OC(C([H])([H])[H])=O)C([H])([H])C(=O)OC([H])([H])OC(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)=O
Formula:	C₄₆H₄₆N₂O₂₃
M.Wt:	994.8571
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

Cat. No.	Product name	Field of application
DC33635	DODAP	DODAP, also known as 1,2-Dioleoyl-3-dimethylammonium-propane, is a cationic lipid. It has been used as a component in liposomes that can be used to encapsulate siRNA, immunostimulatory oligodeoxynucleotides, antisense oligonucleotides, or chemotherapeutic agents for in vitro and in vivo delivery.
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC74583	ZK53	ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP). It exhibits an EC50 of 1.37 μM for α-casein hydrolysis by HsClpP. ZK53 treatment allosterically activates HsClpP to uncontrollably degrade the essential mitochondrial proteins and is inactive toward bacterial ClpP proteins.
DC74576	Fluorofurimazine	Fluorofurimazine is a novel furimazine analogue, with increased aqueous solubility enabling higher signal emission than furimazine for bioluminescence imaging. Fluorofurimazine enables higher substrate loading and improved optical imaging sensitivity in in-vivo.
DC74557	PREX-in1	PREX-in1 is a specific small-molecule inhibitor of P-Rex1 and P-Rex2 Rac-GEF activity with IC50 of 4.5 uM (P-Rex1 DHPH Rac-GEF activity) in liposome-based GEF assay, inhibits P-Rex1 and P-Rex2 through their catalytic DH domain.
DC74555	GYS32661	GYS32661 (GYS 32661) is a potent Rac inhibitor capable of inhibiting both Rac1 and Rac1b, inhibited activated Rac1 with IC50 of 1.18 uM in in vitro pull-down assays.
DC74539	L557-0155	L557-0155 is a small molecule inhibitor of VSIG-8, prevents VSIG-8 binding to VISTA, promotes cytokine production and cell proliferation in PBMCs and suppresses melanoma growth.
DC74528	K284	K284 is a selective small molecule inhibitor of chitinase 3 like1 (CHI3L1) with strong binding affinity (Kd=-9.7 kcal·mol-1), inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
DC74247	AG-946	AG-946 (AG946) is a potent, allosteric activator of wild-type and mutant RBC-specific form of pyruvate kinase (PKR) with AC50 of 5 nM for human wild-type PK, 4.3 nM and 6.9 nM for mutated K410E and R510Q PK proteins, resepctively.
DC74241	Rebecsinib	Rebecsinib (17S-FD-895) is a selective small-molecule inhibitor of splicing-mediated ADAR1 activation, prevents leukemia stem cell generation.